Unknown

Dataset Information

0

Integrin Alpha V in Urine: A Novel Noninvasive Marker for Prostate Cancer Detection.


ABSTRACT: Prostate cancer (PCa) diagnosis based on patient urine analysis provides non-invasive and promising method as compared to biopsy and a prostate-specific antigen (PSA) test. This study was conceived to investigate whether Integrin alpha V (ITGAV) protein is present in urine and assess the urinary ITGAV diagnostic potential for PCa.

Materials and methods

Urinary ITGAV expression was determined by Western blot analysis and quantified by ELISA in urine from men with PCa (n = 47), benign prostate hyperplasia (n = 42) and age-matched controls (n = 22).

Results

The level of ITGAV protein was significantly lower in PCa urine samples as compared to those in the control group (p < 0.00001). The decrease of ITGAV in urine was highly predictive of PCa with 91.5% sensitivity, 91.4% specificity, 0.93 area under the ROC curve, and its specificity was better than that of serum PSA.

Conclusion

Urinary ITGAV provides a novel noninvasive biomarker with high specificity.

SUBMITTER: Zemskova MY 

PROVIDER: S-EPMC8006463 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2019-03-07 | E-MTAB-7732 | biostudies-arrayexpress
| S-EPMC4424114 | biostudies-literature
| S-EPMC9251007 | biostudies-literature
| S-EPMC6597081 | biostudies-literature
| S-EPMC5023772 | biostudies-literature
| S-EPMC5173089 | biostudies-other
| S-EPMC9374213 | biostudies-literature
2007-10-23 | GSE7376 | GEO
| S-EPMC7013283 | biostudies-literature
| S-EPMC6598372 | biostudies-literature